🔗 Share this article

An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Several experts said the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has taken down problematic material and banned associated hashtags and search suggestions. The company said it was committed to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Costs

Inside these groups, posts display black plastic parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already seen patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may subject users to possibly serious health risks”.